Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Aligo Venture Capital is a venture capital fund established in Poland, dedicated to collaborating with entrepreneurs who tackle global challenges. Founded to support projects that aim to mitigate the negative environmental impact of the economy and enhance human health, Aligo has positioned itself as a key player in the early-stage investment landscape.
The firm currently manages a portfolio focused on healthtech and cleantech sectors, with a total AUM that reflects its commitment to these areas. Aligo typically invests in pre-seed and seed stage companies, often acting as the first investor in pre-revenue ventures. The firm has a notable presence in Europe, particularly in Poland, and aims to drive innovation that aligns with its mission of sustainability and health improvement.
Aligo Venture Capital has made significant strides since its inception, with a growing number of investments and a clear focus on supporting entrepreneurs who are building valuable companies. The firm has established a reputation for its active engagement with portfolio companies, ensuring they receive the necessary support to thrive in competitive markets.
Aligo Venture Capital specializes in early-stage investments, primarily targeting companies in the healthtech and cleantech sectors. The fund typically invests between EUR 200,000 and EUR 500,000, often becoming the first investor in pre-revenue startups. This approach allows Aligo to identify and support innovative solutions that leverage technology to improve health outcomes and promote environmental sustainability.
The firm seeks to co-finance investment rounds, either as a sole investor or in collaboration with other investors. Aligo's investment strategy emphasizes projects that address pressing health and environmental challenges, aligning with its mission to foster advancements that can lead to significant societal benefits. The firm looks for founders who demonstrate a strong commitment to their vision and possess the capability to execute their business plans effectively.
Aligo Venture Capital's portfolio includes a diverse range of companies focused on health and environmental solutions. Notable portfolio companies include:
This portfolio reflects Aligo's commitment to investing in innovative solutions that address critical health and environmental issues.
Agnieszka Stochmal - CFO: Agnieszka brings extensive financial expertise to Aligo, having worked in various financial roles prior to joining the firm. She is responsible for overseeing the fund's financial operations and ensuring compliance with regulatory standards.
Łukasz Mańkowski - Managing Partner: Łukasz has a strong background in venture capital and entrepreneurship. He leads the investment strategy at Aligo and has been instrumental in identifying promising startups in the healthtech and cleantech sectors.
Żaneta Kurszewska - Investment Manager: Żaneta focuses on sourcing and evaluating potential investments. Her experience in market analysis and due diligence supports Aligo's investment decisions.
Tomasz Chwiałkowski - Partner: Tomasz has a wealth of experience in the startup ecosystem, providing valuable insights into operational strategies and growth opportunities for portfolio companies.
Mikołaj Pióro - Investment Analyst: Mikołaj supports the investment team with research and analysis, helping to identify trends and opportunities within the healthtech and cleantech markets.
To pitch Aligo Venture Capital, founders should submit their proposals through the project submission page on their website. It is advisable to include a comprehensive deck that outlines the business model, market analysis, and financial projections. Aligo prefers to receive pitches that clearly articulate the problem being solved and the innovative approach taken.
Response times may vary, but founders can expect to hear back within a few weeks. Warm introductions are beneficial but not mandatory. Aligo values direct communication and encourages founders to reach out with any questions regarding their submission.
Recently, Aligo Venture Capital has been active in the investment ecosystem, with a notable blog post discussing the exit of Wellbeing Polska from their portfolio. This exit highlights Aligo's engagement with its portfolio companies and the market.
As of now, no additional blog activity has been detected beyond this post, but the firm continues to monitor its investments closely and remains committed to supporting its portfolio companies.
What are Aligo Venture Capital's investment criteria?
Aligo Venture Capital focuses on early-stage companies in the healthtech and cleantech sectors. They typically invest between EUR 200,000 and EUR 500,000, often at the pre-revenue stage.
How can I apply or pitch to Aligo Venture Capital?
Interested parties can submit projects through Aligo's project submission page available on their website at aligo.vc.
What makes Aligo Venture Capital different from other investors?
Aligo emphasizes a strong commitment to health and environmental sustainability, focusing on innovations that leverage technology to address these challenges. Their active engagement with portfolio companies sets them apart.
What is Aligo's geographic scope for investments?
Aligo Venture Capital primarily invests in early-stage companies located in Europe, with a strong focus on Poland.
What is Aligo's post-investment involvement like?
Aligo actively engages with its portfolio companies, providing support and resources to help them navigate the challenges of early-stage growth.
What is the typical check size for investments?
Aligo typically invests between EUR 200,000 and EUR 500,000 in early-stage companies.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.